Are Middle-aged Male Mice at a Disadvantage?
Often the advice given to a woman with multiple
sclerosis (MS) is not to exacerbate the condition by becoming pregnant. It appears that this advice is about to
change. UCLA neurologists believe
they’ve identified a basis for the controversial claim that the MS relapse rate
for women during pregnancy decreases.
"Apr. 19, 2007 (KABC-TV) - Doctors diagnosed Melissa Glasser with multiple sclerosis at 15. MS is when your own immune system attacks your central nervous system….Despite this, she didn't want MS to stop her from having the family she dreamed of….For decades, scientists knew that something in pregnancy helped women with MS, but there are so many chemical changes researchers didn't know what to isolate. Now, UCLA neurologists say they think they've figured out the answer."
This report highlights estriol which is made in the placenta and has been observed to have the effect of reducing MS symptoms in women and the researchers at UCLA are planning a larger clinical trial with estriol at multiple sites.
The observation of the beneficial effects of estrogen
hormones has been known for many years and it now appears that other estradiol
derivatives, such as 17-beta-estradiol, also have a beneficial effect. A simple Curbside.MD
search "What effect
does estradiol have on the symptoms of MS?" traces what is known about the
field from all the major sources of medical information available. Interestingly, there is an on-going clinical
trial sponsored by the Hospices Civils de
Lyon which hopes to control the symptoms in post-partum women: The POPART’MUS
study is a European, multicentre, randomized, placebo-controlled and
double-blind clinical trial, which aims to prevent MS relapses related to the
post-partum condition, by administering high doses of progestin (nomegestrol
acetate), in combination with endometrial protective doses of estradiol (see
"Clinical Trials").
Unfortunately men may not be able to expect the same benefits from their hormones; research shows the same protective behavior for male mice does not hold. Middle-aged male mice are very sensitive to the symptoms of MS and are unresponsive to testosterone therapy (see “Best Hits”). In this case MS was induced by injection of homogenized brain or spinal cord with Freund’s adjuvant (experimental autoimmune encephalomyelitis).
Still, if male menopause proves to be a real condition rather than just emotional revenge, perhaps more men would consider estrogen therapy and MS might join the growing list of male conditions responsive to female hormones.